You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKesson
Merck
Moodys
Dow
Baxter
Colorcon

Last Updated: April 10, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)

» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00676702 A Study of the Enzyme Activity and Safety of Pancrelipase in Patients With Severe Exocrine Pancreatic Insufficiency (EPI) Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Phase 1 2008-07-01 The purpose of the study is to evaluate the enzyme activity and safety of pancrelipase in patients with severe Exocrine Pancreatic Insufficiency (EPI)
NCT00749099 Bioavailability of Pancreatic Enzymes in the Human Upper Intestine (Duodenum and Jejunum) Terminated St. Louis University N/A 2007-04-01 The overall purpose of this research is to demonstrate (or measure) the intestinal availability of lipase, amylase, and protease (enzymes the body has a shortage of) from PANCRECARB® when administered with a meal.
NCT00749099 Bioavailability of Pancreatic Enzymes in the Human Upper Intestine (Duodenum and Jejunum) Terminated Digestive Care, Inc. N/A 2007-04-01 The overall purpose of this research is to demonstrate (or measure) the intestinal availability of lipase, amylase, and protease (enzymes the body has a shortage of) from PANCRECARB® when administered with a meal.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)

Condition Name

Condition Name for PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)
Intervention Trials
Exocrine Pancreatic Insufficiency 2
Steatorrhea 1
Pancreatitis, Chronic 1
Pancreatitis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)
Intervention Trials
Exocrine Pancreatic Insufficiency 2
Pancreatitis 1
Steatorrhea 1
Pancreatitis, Chronic 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)

Clinical Trial Phase

Clinical Trial Phase for PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)
Clinical Trial Phase Trials
Phase 1 1
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)
Clinical Trial Phase Trials
Completed 1
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)

Sponsor Name

Sponsor Name for PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)
Sponsor Trials
St. Louis University 1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1
Digestive Care, Inc. 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)
Sponsor Trials
Industry 2
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Merck
Mallinckrodt
Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.